Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-28

Clinical Trial Update: Safety and Efficacy of Fenofibrate as a Treatment for Huntington's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on fenofibrate for Huntington's disease, reporting safety and efficacy results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: University of California, Irvine | Conditions: Huntington Disease | Phase 2 | Status: COMPLETED | Results posted: 2023-09-28